Stock Analysis on Net
Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

$24.99

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Paying user area

Try for free

Amgen Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Amgen Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Accounts payable
Sales deductions
Income taxes payable
Employee compensation and benefits
Dividends payable
Accrued interest payable
Other
Accrued liabilities
Current portion of long-term debt
Current liabilities
Long-term debt, excluding current portion
Long-term deferred tax liabilities
Long-term tax liabilities
Other noncurrent liabilities
Noncurrent liabilities
Total liabilities
Common stock and additional paid-in capital; $0.0001 par value per share
Accumulated deficit
Accumulated other comprehensive loss
Stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Amgen Inc. current liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Amgen Inc. noncurrent liabilities as a percentage of total liabilities and stockholders’ equity increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Amgen Inc. total liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2022 to 2023 but then slightly increased from 2023 to 2024.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Amgen Inc. stockholders’ equity as a percentage of total liabilities and stockholders’ equity increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.